Brainsway Ltd
BWAY11.690USD
+0.220+1.92%
Market hours （ET）Quotes delayed by 15 min
441.16MMarket Cap
112.63P/E TTM
More Details of Brainsway Ltd Company
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Company Info
Ticker SymbolBWAY
Company nameBrainsway Ltd
IPO dateDec 24, 2006
CEOMr. Hadar Levy
Number of employees120
Security typeOrdinary Share
Fiscal year-endDec 24
Address16 Hartum Street Rad Tower, 14Th Floor
CityJERUSALEM
Stock exchangeTel Aviv Stock Exchange
CountryIsrael
Postal code9777516
Phone97225813140
Websitehttps://www.brainsway.com/
Ticker SymbolBWAY
IPO dateDec 24, 2006
CEOMr. Hadar Levy
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Moria (Ankri) Ben Soussan
Ms. Moria (Ankri) Ben Soussan
Vice President - Research & Development
Vice President - Research & Development
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Mr. Christopher Boyer
Mr. Christopher Boyer
Vice President - Global Marketing
Vice President - Global Marketing
--
--
Mr. Ido Marom
Mr. Ido Marom
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Aron Tendler, M.D.
Dr. Aron Tendler, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Menachem C. Klein, Esq.
Mr. Menachem C. Klein, Esq.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
--
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Moria (Ankri) Ben Soussan
Ms. Moria (Ankri) Ben Soussan
Vice President - Research & Development
Vice President - Research & Development
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2023
FY2022
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
United States
33.23M
81.01%
Other
7.79M
18.99%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Valor Equity Partners
11.13%
Masters Capital Management, L.L.C.
5.29%
Phoenix Financial Ltd
3.69%
Phoenix Investment and Finances Ltd
1.92%
Acadian Asset Management LLC
1.78%
Other
76.19%
Shareholders
Shareholders
Proportion
Valor Equity Partners
11.13%
Masters Capital Management, L.L.C.
5.29%
Phoenix Financial Ltd
3.69%
Phoenix Investment and Finances Ltd
1.92%
Acadian Asset Management LLC
1.78%
Other
76.19%
Shareholder Types
Shareholders
Proportion
Private Equity
11.13%
Hedge Fund
10.11%
Investment Advisor
5.43%
Investment Advisor/Hedge Fund
4.87%
Holding Company
3.69%
Individual Investor
2.71%
Pension Fund
0.46%
Research Firm
0.30%
Other
61.29%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
82
7.34M
38.87%
+585.20K
2025Q1
84
7.36M
38.96%
-890.13K
2024Q4
77
7.26M
38.54%
-2.72M
2024Q3
65
3.62M
21.68%
-5.03M
2024Q2
59
4.49M
26.92%
-3.10M
2024Q1
56
4.64M
27.89%
-3.35M
2023Q4
48
4.90M
29.50%
-2.87M
2023Q3
43
4.53M
27.32%
-3.32M
2023Q2
45
4.62M
27.86%
-2.51M
2023Q1
50
4.74M
28.65%
-2.28M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Valor Equity Partners
2.10M
11.13%
--
--
Jun 29, 2025
Masters Capital Management, L.L.C.
1.00M
5.29%
--
--
Mar 31, 2025
Phoenix Financial Ltd
697.26K
3.69%
+456.90K
+190.09%
Oct 18, 2024
Phoenix Investment and Finances Ltd
403.99K
2.14%
-78.73K
-16.31%
Mar 31, 2025
Acadian Asset Management LLC
336.58K
1.78%
-16.33K
-4.63%
Mar 31, 2025
Essex Investment Management Company, LLC
303.17K
1.6%
-2.28K
-0.75%
Mar 31, 2025
Renaissance Technologies LLC
298.26K
1.58%
-31.40K
-9.52%
Mar 31, 2025
Shulkin (Jonathan K.)
268.25K
1.42%
+268.25K
--
Nov 05, 2024
Gracias (Antonio J)
243.50K
1.29%
+243.50K
--
Nov 05, 2024
ARK Investment Management LLC
188.33K
1%
+12.74K
+7.26%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
ARK Israel Innovative Technology ETF
2.26%
ActivePassive International Equity ETF
0.02%
iShares Neuroscience and Healthcare ETF
0%
ARK Israel Innovative Technology ETF
Proportion2.26%
ActivePassive International Equity ETF
Proportion0.02%
iShares Neuroscience and Healthcare ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
